Adenosine A(2A) receptor activation reverses hypoxia‑induced rat pulmonary artery smooth muscle cell proliferation via cyclic AMP‑mediated inhibition of the SDF1‑CXC4 signaling pathway

Wang,Yang; Ying,Lei; Jin,Ke‑Ke; Nan,Yan; Hu,Suhua; Wu,Xueqin; Qi,Ruyi; Luo,Xin; Wang,Liangxing

doi:10.3892/ijmm.2018.3626

Adenosine A(2A) receptor activation reverses hypoxia‑induced rat pulmonary artery smooth muscle cell proliferation via cyclic AMP‑mediated inhibition of the SDF1‑CXC4 signaling pathway

Authors:
- Yang Wang
- Lei Ying
- Ke‑Ke Jin
- Yan Nan
- Suhua Hu
- Xueqin Wu
- Ruyi Qi
- Xin Luo
- Liangxing Wang
View Affiliations

Affiliations: Department of Pathophysiology, Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China, Department of Neonatology, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325027, P.R. China, Department of Respiratory Medicine, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China
Published online on: April 16, 2018 https://doi.org/10.3892/ijmm.2018.3626
Pages: 607-614

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The occurrence and the subsequent development of pulmonary arterial hypertension (PAH) involve complicated mechanisms. Of these, the proliferation of pulmonary artery smooth muscle cells (PASMCs) has been indicated to be closely associated with its progression. Therefore, therapeutic methods targeting PASMCs to inhibit proliferation is an effective method for alleviating PAH. The present study was designed to determine the role of the adenosine A(2A) receptor (A2A receptor) in hypoxia‑induced rat PASMC (RPASMC) proliferation. Primary RPASMCs were isolated from the pulmonary artery of adult male SD rats, cultured and used for the following experiments. The mRNA level and protein expression of CXCR4 were measured by reverse transcription‑quantitative polymerase chain reaction and western blot analysis, respectively. The cell proliferation of RPASMCs was measured using a cell proliferation assay kit. In the present study, it was demonstrated that the proliferation of RPASMCs was partially mediated by activation of the stromal cell‑derived factor 1 (SDF1)‑CXC chemokine receptor 4 (CXCR4) axis under hypoxic conditions. In addition, SDF1‑α alone upregulated the mRNA and protein expression levels of CXCR4, and stimulated the proliferation of RPASMCs. The protein expression of CXCR4 and the cell proliferation were markedly inhibited by application of A2A receptor agonist CGS21680 or cyclic adenosine monophosphate (cAMP) under hypoxic conditions or treatment with SDF1‑α and was reversed by the A2A receptor antagonist SCH58261 or 8‑bromoadenosine‑3',5'‑cyclic monophosphorothioate. These results demonstrated that the inhibition of SDF1‑CXC4 signaling by the activation of A2A receptor and subsequent increase in the level of cAMP may be a potential method to ameliorate PAH.

View Figures

View References

1	Dorfmüller P, Humbert M, Capron F and Müller KM: Pathology and aspects of pathogenesis in pulmonary arterial hypertension. Sarcoidosis Vasc Diffuse Lung Dis. 20:9–19. 2003.PubMed/NCBI
2	Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H and Gaine S: Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 43(Suppl 12): 40S–47S. 2004. View Article : Google Scholar : PubMed/NCBI
3	Farber HW and Loscalzo J: Pulmonary arterial hypertension. NEngl J Med. 351:1655–1665. 2004. View Article : Google Scholar
4	Schermuly RT, Ghofrani HA, Wilkins MR and Grimminger F: Mechanisms of disease: Pulmonary arterial hypertension. Nat Rev Cardiol. 8:443–455. 2011. View Article : Google Scholar : PubMed/NCBI
5	Guignabert C, Tu L, Le Hiress M, Ricard N, Sattler C, Seferian A, Huertas A, Humbert M and Montani D: Pathogenesis of pulmonary arterial hypertension: Lessons from cancer. Eur Respir Rev. 22:543–551. 2013. View Article : Google Scholar : PubMed/NCBI
6	Saadjian AY, Paganelli F, Gaubert ML, Levy S and Guieu RP: Adenosine plasma concentration in pulmonary hypertension. Cardiovasc Res. 43:228–236. 1999. View Article : Google Scholar : PubMed/NCBI
7	Konduri GG, Woodard LL, Mukhopadhyay A and Deshmukh DR: Adenosine is a pulmonary vasodilator in newborn lambs. Am Rev Respir Dis. 146:670–676. 1992. View Article : Google Scholar : PubMed/NCBI
8	Pearl RG: Adenosine produces pulmonary vasodilation in the perfused rabbit lung via an adenosine A2 receptor. Anesth Analg. 79:46–51. 1994. View Article : Google Scholar : PubMed/NCBI
9	McCormack DG, Clarke B and Barnes PJ: Characterization of adenosine receptors in human pulmonary arteries. Am J Physiol. 256:H41–H46. 1989.PubMed/NCBI
10	Alencar AK, Pereira SL, Montagnoli TL, Maia RC, Kümmerle AE, Landgraf SS, Caruso-Neves C, Ferraz EB, Tesch R, Nascimento JH, et al: Beneficial effects of a novel agonist of the adenosine A_2A receptor on monocrotaline-induced pulmonary hypertension in rats. Br J Pharmacol. 169:953–962. 2013. View Article : Google Scholar :
11	Xu MH, Gong YS, Su MS, Dai ZY, Dai SS, Bao SZ, Li N, Zheng RY, He JC, Chen JF and Wang XT: Absence of the adenosine A_2A receptor confers pulmonary arterial hypertension and increased pulmonary vascular remodeling in mice. J Vasc Res. 48:171–183. 2011. View Article : Google Scholar
12	Shang P, He ZY, Chen JF, Huang SY, Liu BH, Liu HX and Wang XT: Absence of the adenosine A_2A receptor confers pulmonary arterial hypertension through RhoA/ROCK signaling pathway in mice. J Cardiovasc Pharmacol. 66:569–575. 2015. View Article : Google Scholar : PubMed/NCBI
13	Alencar AK, Pereira SL, da Silva FE, Mendes LV, Cunha Vdo M, Lima LM, Montagnoli TL, Caruso-Neves C, Ferraz EB, Tesch R, et al: N-acylhydrazone derivative ameliorates monocrotaline-induced pulmonary hypertension through the modulation of adenosine AA2R activity. Int J Cardiol. 173:154–162. 2014. View Article : Google Scholar : PubMed/NCBI
14	Huang X, Zou L, Yu X, Chen M, Guo R, Cai H, Yao D, Xu X, Chen Y, Ding C, et al: Salidroside attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A_2A receptor related mitochondria-dependent apoptosis pathway. J Mol Cell Cardiol. 82:153–166. 2015. View Article : Google Scholar : PubMed/NCBI
15	Zernecke A, Schober A, Bot I, von Hundelshausen P, Liehn EA, Möpps B, Mericskay M, Gierschik P, Biessen EA and Weber C: SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ Res. 96:784–791. 2005. View Article : Google Scholar : PubMed/NCBI
16	Schober A: Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol. 28:1950–1959. 2008. View Article : Google Scholar : PubMed/NCBI
17	Young KC, Torres E, Hatzistergos KE, Hehre D, Suguihara C and Hare JM: Inhibition of the SDF-1/CXCR4 axis attenuates neonatal hypoxia-induced pulmonary hypertension. Circ Res. 104:1293–1301. 2009. View Article : Google Scholar : PubMed/NCBI
18	Yu L and Hales CA: Effect of chemokine receptor CXCR4 on hypoxia-induced pulmonary hypertension and vascular remodeling in rats. Respir Res. 12:212011. View Article : Google Scholar : PubMed/NCBI
19	Farkas D, Kraskauskas D, Drake JI, Alhussaini AA, Kraskauskiene V, Bogaard HJ, Cool CD, Voelkel NF and Farkas L: CXCR4 inhibition ameliorates severe obliterative pulmonary hypertension and accumulation of C-kit⁺ cells in rats. PLoS One. 9:e898102014. View Article : Google Scholar
20	Wei L, Zhang B, Cao W, Xing H, Yu X and Zhu D: Inhibition of CXCL12/CXCR4 suppresses pulmonary arterial smooth muscle cell proliferation and cell cycle progression via PI3K/Akt pathway under hypoxia. J Recept Signal Transduct Res. 35:329–339. 2015. View Article : Google Scholar
21	By Y, Durand-Gorde JM, Condo J, Lejeune PJ, Fenouillet E, Guieu R and Ruf J: Monoclonal antibody-assisted stimulation of adenosine A_2A receptors induces simultaneous downregulation of CXCR4 and CCR5 on CD4⁺ T-cells. Hum Immunol. 71:1073–1076. 2010. View Article : Google Scholar : PubMed/NCBI
22	Nolan T, Hands RE and Bustin SA: Quantification of mRNA using real-time RT-PCR. Nat Protoc. 1:1559–1582. 2006. View Article : Google Scholar
23	Ji JF, He BP, Dheen ST and Tay SS: Expression of chemokine receptors CXCR4, CCR2, CCR5 and CX3CR1 in neural progenitor cells isolated from the subventricular zone of the adult rat brain. Neurosci Lett. 355:236–240. 2004. View Article : Google Scholar : PubMed/NCBI
24	Wang Y, Deng Y and Zhou GQ: SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res. 1195:104–112. 2008. View Article : Google Scholar : PubMed/NCBI
25	Dahal BK, Heuchel R, Pullamsetti SS, Wilhelm J, Ghofrani HA, Weissmann N, Seeger W, Grimminger F and Schermuly RT: Hypoxic pulmonary hypertension in mice with constitutively active platelet-derived growth factor receptor-β. Pulm Circ. 1:259–268. 2011. View Article : Google Scholar : PubMed/NCBI
26	Jie W, Wang X, Zhang Y, Guo J, Kuang D, Zhu P, Wang G and Ao Q: SDF-1α/CXCR4 axis is involved in glucose-potentiated proliferation and chemotaxis in rat vascular smooth muscle cells. Int J Exp Pathol. 91:436–444. 2010. View Article : Google Scholar : PubMed/NCBI
27	Pan CH, Chen CW, Sheu MJ and Wu CH: Salvianolic acid B inhibits SDF-1α-stimulated cell proliferation and migration of vascular smooth muscle cells by suppressing CXCR4 receptor. Vascul Pharmacol. 56:98–105. 2012. View Article : Google Scholar
28	Hong KW, Shin HK, Kim HH, Choi JM, Rhim BY and Lee WS: Metabolism of cAMP to adenosine: Role in vasodilation of rat pial artery in response to hypotension. Am J Physiol. 276:H376–H382. 1999.PubMed/NCBI
29	Carroll MA, Doumad AB, Li J, Cheng MK, Falck JR and McGiff JC: Adenosine 2A receptor vasodilation of rat preglomerular microvessels is mediated by EETs that activate the cAMP/PKA pathway. Am J Physiol Renal Physiol. 291:F155–F161. 2006. View Article : Google Scholar : PubMed/NCBI
30	Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF and Rabinovitch M: Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol. 43(Suppl 12): 13S–24S. 2004. View Article : Google Scholar : PubMed/NCBI
31	Morrell NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, McMurtry IF, Stenmark KR, Thistlethwaite PA, Weissmann N, et al: Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol. 54(Suppl 1): S20–S31. 2009. View Article : Google Scholar : PubMed/NCBI
32	Stenmark KR, Fagan KA and Frid MG: Hypoxia-induced pulmonary vascular remodeling: Cellular and molecular mechanisms. Circ Res. 99:675–691. 2006. View Article : Google Scholar : PubMed/NCBI
33	Kato M and Staub NC: Response of small pulmonary arteries to unilobar hypoxia and hypercapnia. Circ Res. 19:426–440. 1966. View Article : Google Scholar : PubMed/NCBI
34	Hein TW and Kuo L: cAMP-independent dilation of coronary arterioles to adenosine: Role of nitric oxide, G proteins, and K(ATP) channels. Circ Res. 85:634–642. 1999. View Article : Google Scholar : PubMed/NCBI
35	Murphy K, Gerzanich V, Zhou H, Ivanova S, Dong Y, Hoffman G, West GA, Winn HR and Simard JM: Adenosine-A_2A receptor down-regulates cerebral smooth muscle L-type Ca2+ channel activity via protein tyrosine phosphatase, not cAMP-dependent protein kinase. Mol Pharmacol. 64:640–649. 2003. View Article : Google Scholar : PubMed/NCBI